On September 23, 2026 Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biopharmaceutical company developing therapeutics using its proprietary INTASYL siRNA gene silencing technology to eliminate cancer, reported that it will present at the Life Sciences Future 2026 Conference, taking place September 30 to October 1, 2026, at the Sheraton Valley Forge Hotel in King of Prussia, Pennsylvania.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Robert Bitterman, President and Chief Executive Officer, will provide an update on the Company’s completed Phase 1b clinical study of PH-762 in cutaneous squamous cell carcinoma (cSCC), including planned next steps designed to advance the program toward its next stage of clinical development.
The presentation will highlight Phio’s strategy to build on the favorable safety profile demonstrated in the Phase 1b study and discuss key upcoming clinical, regulatory, and development objectives intended to unlock further value from the PH-762 program.
"Our participation at Life Sciences Future Conference provides an opportunity to share our progress with investors, industry leaders, and potential strategic partners," said Robert Bitterman, CEO and President, Phio Pharmaceuticals. "We look forward to discussing the advancement of PH-762 and the significant potential of our INTASYL platform to address unmet needs in cancer treatment."
In addition to the company presentation, members of Phio’s management team will be available for one-on-one meetings throughout the conference.
Presentation Details:
Date: September 30, 2026
Time: 10:20 AM (ET)
Event: Life Sciences Future 2026 Conference
Location: Sheraton Valley Forge Hotel, King of Prussia, Pennsylvania
Life Sciences Future is the annual gathering of Pennsylvania’s life sciences community, hosted by Life Sciences PA, bringing together biotechnology and pharmaceutical companies, research institutions, investors, strategic partners, and industry advisors to discuss innovation and opportunities across the life sciences sector.
(Press release, Phio Pharmaceuticals, SEP 23, 2026, View Source [SID1234671032])